Search Results

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    A phase I/II trial to evaluate the safety, feasibility and activity of salvage therapy consisting of the mTOR inhibitor Temsirolimus added to standard therapy of Rituximab and DHAP... by Witzens-Harig, Mathias (Author) , Memmer, Marie-Luise (Author) , Dreyling, Martin (Author) , Hess, Georg (Author) ,


    Get full text
    Article (Journal) Online Resource
  2. 2

    Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of... by Luber, Birgit (Author) , Deplazes, Joëlle (Author) , Keller, Gisela (Author) , Walch, Axel (Author) , Rauser, Sandra (Author) , Eichmann, Martin (Author) , Langer, Rupert (Author) , Höfler, Heinz (Author) , Hegewisch-Becker, Susanna (Author) , Folprecht, Gunnar (Author) , Wöll, Ewald (Author) , Decker, Thomas (Author) , Endlicher, Esther (Author) , Lorenzen, Sylvie (Author) , Fend, Falko (Author) , Peschel, Christian (Author) , Lordick, Florian (Author) ,


    Get full text
    Article (Journal) Online Resource
  3. 3

    Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial by Witzens-Harig, Mathias (Author) , Hensel, Manfred (Author) , Unterhalt, Michael (Author) , Herfarth, Klaus (Author) ,


    Get full text
    Article (Journal) Online Resource